about
The Epidemiology of Chronic Pain of Predominantly Neuropathic Origin. Results From a General Population SurveyCoordinate-based meta-analysis of experimentally induced and chronic persistent neuropathic painPsychological therapies for the management of chronic neuropathic pain in adultsPsychological therapies for the management of chronic neuropathic pain in adultsGabapentin for chronic neuropathic pain and fibromyalgia in adultsCarbamazepine for chronic neuropathic pain and fibromyalgia in adultsTopical capsaicin (low concentration) for chronic neuropathic pain in adultsTopical capsaicin (high concentration) for chronic neuropathic pain in adultsLamotrigine for chronic neuropathic pain and fibromyalgia in adultsGabapentin for chronic neuropathic pain and fibromyalgia in adultsTopical capsaicin for chronic neuropathic pain in adultsGabapentin for chronic neuropathic pain in adultsTopical capsaicin for chronic neuropathic pain in adultsComparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: randomised, crossover, double blind studyCapnellene, a natural marine compound derived from soft coral, attenuates chronic constriction injury-induced neuropathic pain in ratsMechanisms of chronic central neuropathic pain after spinal cord injuryPharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain SocietyCannabinoids for chronic neuropathic painInhaled Cannabis for Chronic Neuropathic Pain: A Meta-analysis of Individual Patient DataDisruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic painTranscranial magnetic resonance imaging-guided focused ultrasound: noninvasive central lateral thalamotomy for chronic neuropathic painRole of serotonin 5-HT1A and opioid receptors in the antiallodynic effect of tramadol in the chronic constriction injury model of neuropathic pain in ratsNovel epigallocatechin-3-gallate (EGCG) derivative as a new therapeutic strategy for reducing neuropathic pain after chronic constriction nerve injury in miceFunctional reduction in mu-opioidergic system in the spinal cord under a neuropathic pain-like state following chronic ethanol consumption in the rat[Effect of electroacupuncture on the expression of spinal glial fibrillary acidic protein, tumor necrosis factor-alpha and interleukin-1beta in chronic neuropathic pain rats]An improved behavioural assay demonstrates that ultrasound vocalizations constitute a reliable indicator of chronic cancer pain and neuropathic pain.Targeting chronic and neuropathic pain: the N-type calcium channel comes of age.Chronic motor cortex stimulation in the treatment of central and neuropathic pain. Correlations between clinical, electrophysiological and anatomical data.Vestibular dysfunction in patients with chronic pain or underlying neurologic disorders.Brain signature of chronic orofacial pain: a systematic review and meta-analysis on neuroimaging research of trigeminal neuropathic pain and temporomandibular joint disordersHydromorphone extended release for neuropathic and non-neuropathic/nociceptive chronic low back pain: a post hoc analysis of data from a randomized, multicenter, double-blind, placebo-controlled clinical trial.Deep brain stimulation of the dorsal anterior cingulate cortex for the treatment of chronic neuropathic pain.Summaries of nursing care-related systematic reviews from the Cochrane Library: Topical capsaicin for chronic neuropathic pain in adults.Brain activity modifications following spinal cord stimulation for chronic neuropathic pain: A systematic review.Motor cortex stimulation for long-term relief of chronic neuropathic pain: a 10 year experience.[Maladaptive plasticity in chronic and neuropathic pain].Efficacy and tolerability balance of oxycodone/naloxone and tapentadol in chronic low back pain with a neuropathic component: a blinded end point analysis of randomly selected routine data from 12-week prospective open-label observations.Proteomic analysis of differential proteins related to the neuropathic pain and neuroprotection in the dorsal root ganglion following its chronic compression in rats.Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin: systematic review and economic evaluation.[Peripheral anti-hyperalgesic effect and neurotoxicologic screening of amitriptyline and bupivacaine on sciatic nerve blockade chronically on neuropathic pain in rats].
P921
Q182155-b20f69d6-4069-801c-c629-5232d4f7dc9eQ18554094-66d2212f-4adb-8491-313a-578dc06a5949Q201989-2bcc7eff-473f-5894-da7c-0f37b6db5921Q2046550-9beb7264-4ca8-f961-c318-8b62931bc737Q2642518-a3ca6b87-4890-9749-ca8c-6a26f59b3a4fQ615645-65ed5579-4868-85f9-ae2f-e723d8f26425Q8277-a1877263-49db-3fde-4340-10c6315e2dd8
P780
Q21710682-22e4d0fa-d874-43ec-8a5b-e6f4b407fd9eQ23992192-8b234047-b43a-4e0e-ad92-bc201ccba050Q24186321-3075ab7a-fd67-418d-8a4c-348eb36b998bQ24194611-f3accd82-c921-40bd-85d6-6e9ea256fdbbQ24194998-e6f71d8e-2c36-477b-b116-07a891097297Q24197459-a7b1495e-48e7-41f2-bbd8-c96ae9f57011Q24200378-f568804a-2136-4fe5-9528-d0d007ae11acQ24200709-c64be901-9b5c-4cc1-aac2-0dd3fb4af90cQ24201979-e8eb61af-a676-410e-beb9-0ff4edfc6266Q24235709-97d7c842-3780-41af-a5fd-d2e01e2780aeQ24240399-36a2ea4e-abff-4777-bc4b-641ee19cf757Q24240890-bcf94bf8-6c4f-4a52-8425-924a22746c0dQ24242543-cd145cca-838c-4f0b-9f33-61b8d29d4ab8Q24645385-9fbd75ea-9b3f-4736-8fc7-c87f67e0c3d6Q24649995-dffd4a66-97c7-496f-903b-3bc27f439040Q24655280-5a6f7a96-6798-4fbf-b99e-7cd1141f91f2Q24657295-df2a2df8-3f50-4e4b-8668-cdbfa7adbf8aQ26472068-c53c090c-ff71-47b6-a129-79d8ccf929bcQ28084769-ac10f546-980f-481d-8028-e54072a9733aQ28240653-91990928-6824-45e9-b2ff-dd4361751804Q28256330-7966492f-41f4-4eaa-a4b8-ba55545be989Q28295546-4fcce705-8a21-490f-9537-522cd301cfb2Q28546011-9959092c-7569-42bd-b161-e75cc21af913Q28566822-0f5c7dce-58d5-4ed3-b50b-9af9f7543ce7Q28571363-22035faa-d482-4497-a925-3f61008acff5Q30481964-011b5241-67f8-496e-8de1-fc5b5e3536a2Q30501239-db956a1a-2769-4a96-8496-435e1db9a0d0Q30581673-10fcb66e-8a2c-4df8-b0c8-62d584dd1240Q30764200-2619c535-8a72-4bb1-bf88-1bb05d58e034Q30807624-c0424d2f-3f90-44e1-9d16-f70d85a81ce1Q30864747-9dc5b409-3133-44db-bf3d-b557d6104672Q30962258-297d6cdd-e418-4dba-86de-dc9616b18b7eQ30993752-27db045d-86a9-46e7-9ec0-880c28be3008Q30999838-8efa9b2c-735b-46aa-bb1a-88bed8f5c96aQ31032449-bc954a87-8fa9-4b33-b4a1-86594198ed34Q31033338-be6f3477-11b9-4aed-9609-30bffadee27dQ31144449-e37bd2d8-b9f3-450c-866b-adf029e3562fQ33336630-bf3ef3c2-1f79-4b5c-a7b4-6ddc8632ac2cQ33424120-c1669212-d5d5-4896-864b-1c9b22bc5309Q33491650-30e48b68-5aa6-4a30-a740-35598cb996b7
P921
description
pain caused by damage to the somatosensory nervous system damage
@en
ցավ պայմանավորված մարմնազգայական նյարդային համակարգի վնասումով
@hy
name
chronic neuropathic pain
@en
dolor neuropàtic crònic
@ca
dolor neuropático crónico
@es
min neuropatiko kroniko
@eu
хронічний нейропатичний біль
@uk
Քրոնիկական նեյրոպաթիկ ցավ
@hy
type
label
chronic neuropathic pain
@en
dolor neuropàtic crònic
@ca
dolor neuropático crónico
@es
min neuropatiko kroniko
@eu
хронічний нейропатичний біль
@uk
Քրոնիկական նեյրոպաթիկ ցավ
@hy
altLabel
MG30.5
@en
prefLabel
chronic neuropathic pain
@en
dolor neuropàtic crònic
@ca
dolor neuropático crónico
@es
min neuropatiko kroniko
@eu
хронічний нейропатичний біль
@uk
Քրոնիկական նեյրոպաթիկ ցավ
@hy